Mao Y - Search Results

1

Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines.

Zhao M, Zhai Y, Zai X, Mao Y, Hu E, Wei Z, Li Y, Li K, Liu Y, Xu J, Yu R, Chen W. Zhao M, et al. Among authors: mao y. Front Cell Infect Microbiol. 2023 May 25;13:1195314. doi: 10.3389/fcimb.2023.1195314. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37305410 Free PMC article.

2

Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection.

Yu R, Mao Y, Li K, Zhai Y, Zhang Y, Liu S, Gao Y, Chen Z, Liu Y, Fang T, Zhao M, Li R, Xu J, Chen W. Yu R, et al. Among authors: mao y. Mediators Inflamm. 2021 Apr 21;2021:9979032. doi: 10.1155/2021/9979032. eCollection 2021. Mediators Inflamm. 2021. PMID: 33967626 Free PMC article.

3

Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.

Yu R, Lin Q, Zhai Y, Mao Y, Li K, Gao Y, Liu Y, Fu L, Fang T, Zhao M, Guan L, Hou L, Xu J, Chen W. Yu R, et al. Among authors: mao y. Microb Biotechnol. 2021 Sep;14(5):2152-2163. doi: 10.1111/1751-7915.13897. Epub 2021 Jul 28. Microb Biotechnol. 2021. PMID: 34318587 Free PMC article.

4

Recombinant Human Thymosin β4 (rhTβ4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease.

Zhai Y, Zheng X, Mao Y, Li K, Liu Y, Gao Y, Zhao M, Yang R, Yu R, Chen W. Zhai Y, et al. Among authors: mao y. Int J Mol Sci. 2022 May 13;23(10):5458. doi: 10.3390/ijms23105458. Int J Mol Sci. 2022. PMID: 35628276 Free PMC article.

5

Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway.

Yu R, Gao D, Bao J, Sun R, Cui M, Mao Y, Li K, Hu E, Zhai Y, Liu Y, Gao Y, Xiao T, Zhou H, Yang C, Xu J. Yu R, et al. Among authors: mao y. Int J Mol Sci. 2023 Feb 14;24(4):3818. doi: 10.3390/ijms24043818. Int J Mol Sci. 2023. PMID: 36835236 Free PMC article.

6

Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.

Shi DY, Chen BY, Mao YY, Zhou G, Lu JS, Yu YZ, Zhou XW, Sun ZW. Shi DY, et al. Hum Vaccin Immunother. 2019;15(3):755-760. doi: 10.1080/21645515.2018.1547613. Epub 2018 Dec 4. Hum Vaccin Immunother. 2019. PMID: 30433836 Free PMC article.

7

Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.

Shi DY, Liu FJ, Mao YY, Cui RT, Lu JS, Yu YZ, Dong XJ, Yang ZX, Sun ZW, Pang XB. Shi DY, et al. Hum Vaccin Immunother. 2020;16(1):100-108. doi: 10.1080/21645515.2019.1633878. Epub 2019 Jul 26. Hum Vaccin Immunother. 2020. PMID: 31210561 Free PMC article.

8

Development and evaluation of a tetravalent botulinum vaccine.

Shi DY, Liu FJ, Li ZY, Mao YY, Lu JS, Wang R, Pang XB, Yu YZ, Yang ZX. Shi DY, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2048621. doi: 10.1080/21645515.2022.2048621. Epub 2022 Apr 18. Hum Vaccin Immunother. 2022. PMID: 35435814 Free PMC article.

9

Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.

Liu FJ, Shi DY, Mao YY, Xiong XH, Lu JS, Pang XB, Dong XJ, Yang ZX, Yu YZ. Liu FJ, et al. Vaccine. 2020 Mar 23;38(14):2978-2983. doi: 10.1016/j.vaccine.2020.02.060. Epub 2020 Feb 26. Vaccine. 2020. PMID: 32113807

10

Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.

Shi DY, Lu JS, Mao YY, Liu FJ, Wang R, Du P, Yu S, Yu YZ, Yang ZX. Shi DY, et al. Appl Microbiol Biotechnol. 2023 May;107(10):3205-3216. doi: 10.1007/s00253-023-12515-2. Epub 2023 Apr 14. Appl Microbiol Biotechnol. 2023. PMID: 37058230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,830 results

Search Page